Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-161-1 | CAS number: 1103-39-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 32 mg/kg bw/day
- Study duration:
- chronic
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Read across justification
Toxicity to reproduction of the test substance was not examined. The test item shares structural similarity to an analogue substance. Both are Ba-salts and include 1 -amino-2 -naphthol which is connected via azo bond with an aromatic sulfonic acid. Enzymatic azo reduction of the substances may lead to release of 1-amino-2 -naphthol. The salts are poor soluble in water and octanol and dissolve most likely in an acidic environment (e.g. stomach). Therefore, it is acceptable to derive information on reproductive-toxicity from experimental data of the analogue substance.
Procedure and observationsThe test material, D&C Red No. 9, was administered to rats in the diet at concentrations of 100, 200 and 500 ppm (equ. to 8, 14 and 42 mg/kg bw/day) for 8 weeks prior to mating (CFTA 1982). The treatment was continued during gestation and lactation. The test material was judged not to have an effect on body weight, food consumption, or fertility of the F0 generation rats. Similarly, no effect was evident on the viability or growth of F1 pups from birth to weaning. Rats from parents treated with graded dietary concentrations of D&C Red No. 9 (0, 100, 200 and 500 ppm) have been continued on treatment for 30 months after weaning. The only difference between the treated groups and the control (0 ppm) groups now judged to be related to the test material is the increase in the spleen weight in the high dose females at the 12 month interval. The apparent decreased values of red cell parameters seen at 12 months were not evident at 18 or 24 months. The gross and histopathologic evaluation and the tumor incidence analyses of the animals did not reveal any compound related effect.
In a multi-generation reproduction study in Charles River CD rats, D & C Red #9 was fed in the diet at dosage levels of 0. 05, 0.5, 1. 5 and 5.0 mg/kg/day. Ten male and 20 female rats were used in each treated group and also as a control group. No changes considered to be related to compound were seen for parental rats or pups with respect to general behavior or appearance, body weight or survival. The fertility, gestation, viability and lactation indices of all litters were comparable for the control and treated groups. An examination of the ovaries and uteri of all dams sacrificed on day 19 of gestation in the F2c litter failed to reveal any abnormal gross anatomical changes. No unusual changes were observed in the examination of pups stillborn or dying during the study. No compound related gross or microscopic pathologic lesions were observed in any F1 or F3a rats from this study which were sacrificed and necropsied. No compound related organ weight variations were observed at sacrifice in F 1 parental rats.
Short description of key information:
Toxicity to reproduction of the test substance was not examined. Reliable experimental data on a structural analogue are available. The test material, D&C Red No. 9, was administered to rats in the diet at concentrations of 100, 200 and 500 ppm (equ. to 8, 14 and 42 mg/kg bw/day) for 8 weeks prior to mating (CFTA 1982). The treatment was continued during gestation and lactation. Rats from parents treated with graded dietary concentrations of D&C Red No. 9 (0, 100, 200 and 500 ppm) have been continued on treatment for 30 months after weaning. The test material was judged not to have an effect on body weight, food consumption, or fertility of the F0 generation rats. Similarly, no effect was evident on the viability or growth of F1 pups from birth to weaning. In a multi-generation reproduction study the test item was fed in the diet at dosage levels of 0. 05, 0.5, 1. 5 and 5.0 mg/kg/day to male and female rats. No changes seen for parental rats or pups with respect to general behavior or appearance, body weight or survival. The fertility, gestation, viability and lactation indices of all litters were comparable to control. Abnormal gross anatomical changes or microscopic pathologic lesions were not observed.
Effects on developmental toxicity
Description of key information
Developmental toxicity of the test substance was not examined. Reliable experimental data on a structural analogue are available. In two teratology studies in female rats and female rabbits, respectively, the test item was administered by gavage at dosage levels of 1.5, 5.0 and 15.0 mg/kg/ day. Positive control groups received retinoic acid or Thalidomide. No changes in behavior and appearance or effects on body weight were observed. No effect upon any maternal (body weight, corpora lutea, empty implantation sites, early resorptions, late resorptions, and live or dead term fetuses) or fetal (mean body weight, sex, external, internal and skeletal abnormalities) parameters evaluated was seen at any dose level.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 15 mg/kg bw/day
- Species:
- other: rats and rabbits
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Read across justification
Toxicity to reproduction of the test substance was not examined.The test item sharesstructural similarity to an analogue substance. Both are Ba-salts and include 1 -amino-2 -naphthol which is connected via azo bond with an aromatic sulfonic acid. Enzymatic azo reduction of the substances may lead to release of 1-amino-2 -naphthol. The saltsare poor soluble in water and octanol and dissolve most likely in an acidic environment (e.g. stomach). Therefore, it is acceptable to derive information on reproductive-toxicity from experimental data of the analogue substance.
Procedure and observation
In a teratology study in female Charles River CD rats, the test item was administered by gavage at dosage levels of 1.5, 5.0 and 15.0 mg/kg/ day. Three negative control groups of rats received the vehicle, 0.5% Methocel, and a positive control group of rats received 7. 5 mg/kg/day of retinoic acid. All rats received the compounds or vehicle on days 6 through 15 of gestation. Twenty pregnant rats were used in each control and treated group. No changes in behavior or appearance considered to be related to the material were observed. Increases in body weight were similar for control and treated rats. Cesarean sections were done on the 20th day of gestation. No compound related effect upon any maternal (body weight, corpora lutea, empty implantation sites, early resorptions, late resorptions, and live or dead term fetuses) or fetal (mean body weight, sex, external, interaal and skeletal abnormalities) parameters evaluated was seen in any dose group.
In a teratology study in female Dutch Belted rabbits, the test item was administered by gavage at dosage levels of 1.5, 5.0 and 15.0 mg/kg/ day. Three negative control groups of rabbits received the vehicle, 0.5% Methocel, and a posit:ive control group of rabbits received 150 mg/kg/day of Thalidomide. All rabbits received the compounds or vehicle on days 6 through 18 of gestation. Ten pregnant rabbits were used in each control and treated group. No changes in behavior and appearance were observed. Changes in body weight were similar for control and treated rabbits. Cesarean sections were done on t.he 29th day of gestation. No effect upon any maternal (body weight, corpora lutea, empty implantation sites, early resorptions, late resorptions, and live or dead term fetuses) or fetal (mean body weight, sex, external, internal and skeletal abnormalities) parameters evaluated was seen at any dose level. Several abnormalities occurred in single fetuses without an indication of a dosage relationship. These conditions were considered spontaneaus in origin.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for reproductive toxicity under Directive 67 / 548 / EEC.
Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for reproductive toxicity under Regulation (EC) No. 1272/2008.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.